Thomas Chatzikonstantinou
About
In The Last Decade
Thomas Chatzikonstantinou
17 papers receiving 487 citations
Hit Papers
Peers
Comparison fields: 5 of 55
- Oncology 246
- Infectious Diseases 242
- Immunology 114
- Genetics 97
- Hematology 68
Countries citing papers authored by Thomas Chatzikonstantinou
This map shows the geographic impact of Thomas Chatzikonstantinou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Chatzikonstantinou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Chatzikonstantinou more than expected).
Fields of papers citing papers by Thomas Chatzikonstantinou
This network shows the impact of papers produced by Thomas Chatzikonstantinou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Chatzikonstantinou. The network helps show where Thomas Chatzikonstantinou may publish in the future.
Co-authorship network of co-authors of Thomas Chatzikonstantinou
This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Chatzikonstantinou. A scholar is included among the top collaborators of Thomas Chatzikonstantinou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Chatzikonstantinou. Thomas Chatzikonstantinou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 8 | |
| 3 | 2 | |
| 4 | 2 | |
| 5 | 8 | |
| 6 | 41 | |
| 7 | 0 | |
| 8 | 2 | |
| 9 | 3 | |
| 10 | 4 | |
| 11 | 4 | |
| 12 | 6 | |
| 13 | 3 | |
| 14 | 26 | |
| 15 | Outcomes of patients with hematologic malignancies and COVID-19: a systematic review and meta-analysis of 3377 patients breakdown → | 330 |
| 16 | 0 | |
| 17 | 29 | |
| 18 | 9 | |
| 19 | 8 | |
| 20 | 10 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.